Drugs / Spirit1
last change May 2022 re-read 3 minutes ago

Spirit1

Developed for
amyotrophic lateral sclerosis
Investigated by
Carmel Medical Center · Herb Spirit

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02588807 Jan → Sep 2021 amyotrophic lateral sclerosis Herb Spirit Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Spirit 1 “Spirit 1 is a combination of phospholipids and anti-oxidant medicinal plants” NCT02588807 ↗
1

NCT02588807 ↗